Kenjiro Okamoto
Papers
3
Total Citations
8
H-Index
2
About
Dr. Kenjiro Okamoto is a pioneering urologic surgeon and researcher whose work centers on advancing minimally invasive surgical techniques for genitourinary cancers, particularly renal cell carcinoma and bladder cancer. His major contributions lie in evaluating the safety and efficacy of robot-assisted surgery across diverse patient populations. In his landmark 2024 study, "Robot-assisted partial nephrectomy in younger versus older adults with renal cell carcinoma," he employed propensity score-matched analysis to demonstrate that robotic nephron-sparing surgery is equally effective and safe for elderly patients, challenging age-based treatment biases. This work has already garnered 5 citations, reflecting its immediate clinical relevance. Dr. Okamoto has also led multicenter comparative studies on robotic versus open radical cystectomy, notably examining retroperitoneal cutaneous ureterostomy outcomes and the impact of lymph node dissection on surgical and oncological results. His research consistently emphasizes perioperative outcomes, stent-free rates, and readmission metrics, providing evidence-based guidance for surgical decision-making. By systematically comparing robotic and open approaches, Dr. Okamoto is helping to define the optimal role of robotics in complex urologic oncology, making him a key voice in the evolution of modern surgical practice.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3